Log In
BCIQ
Print this Print this
 

Human proislet peptide (HIP) (CDM1101)

  Manage Alerts
Collapse Summary General Information
Company CureDM Inc.
DescriptionHuman proislet peptide (HIP) that stimulates the differentiation of adult pancreatic progenitor cells into insulin-producing islets
Molecular Target Regenerating islet-derived 3 alpha (REG3A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$335.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/12/2010

$335.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today